Home » Topics » BioWorld Science

BioWorld Science
RSS

OR2AT4 identified as a new therapeutic target in COPD

Sep. 8, 2021

Study of beta-arrestin isoforms may alter development of drugs targeting GPCRs

Sep. 8, 2021

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Sep. 8, 2021

Adaptimmune and Genentech collaborate on allogeneic cell therapies for cancer

Sep. 7, 2021

Insilico Medicine and University of Cambridge collaborate on protein liquid-liquid phase separation

Sep. 7, 2021

In vitro lung models of COVID-19 developed using stem cell-derived human lung organoids

Sep. 7, 2021

BCL7A predicts outcome in glioma patients

Sep. 7, 2021

CRP, ferritin and D-dimer as biomarkers for predicting COVID-19 pneumonia progression

Sep. 7, 2021

NeuExcell, Spark Therapeutics enter collaboration to develop gene therapy for Huntington's disease

Sep. 7, 2021

Discovery of novel new anti-cryptosporidial lead, SLU-2633

Sep. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...